Interestingly, a putatively relapse-associated mutation in ARID4B has been identified in pediatric T-ALL [31], and ARID5B has been associated with germline susceptibility to pediatric ALL [32]. This evidence concerns the gene ARID5B and acute lymphoblastic leukemia.